Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The annual meeting runs April 25 ...

Turbine's virtual lab enables in silico experimentation using a vast library of cell models, patient-derived samples and virtual patients. By computationally predicting therapy effects, drug ...

Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Today, as we mark World Malaria Day, we're highlighting innovative approaches that can drive progress toward eliminating this ...

Negative Breast Cancer Market Insight, Epidemiology and Market Forecast - 2035" report delivers comprehensive insights into triple-negative breast cancer, i ...

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

A team of researchers led by the University of Bonn has now identified a promising bioactive compound that could effectively ...

Invited oral presentation includes in vivo proof-of-concept data for AI-identified targeted therapies to be incorporated into ADCs to treat early-stage lung adenocarcinoma. CAMBRIDGE, MA / ACCESS ...

Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative ...